跳至主要内容
临床试验/NCT06614010
NCT06614010招募中1 期

Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery

Qianfoshan Hospital1 个研究点 分布在 1 个国家目标入组 207 人开始时间: 2023年2月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
207
试验地点
1
主要终点
Incidence of awakening agitation

研究概览

简要总结

To examine the impact of various administration routes of dexmedetomidine in conjunction with ultrasound-guided fascia iliaca block (FIB) on emergence agitation (EA) during the postoperative recovery period after hip replacement surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age between 18 and 65 years, with no restriction on gender
  • diagnosis of hip joint disease necessitating hip arthroplasty
  • ASA grade I-II
  • no significant cardiopulmonary, hepatic, or renal dysfunction prior to the operation
  • no history of psychiatric disorders or long-term use of sedative medications prior to the operation
  • signing of an informed consent form to voluntarily participate in the study.

排除标准

  • patients allergic to or with contraindications to ropivacaine or dexmedetomidine
  • patients exhibiting symptoms of agitation or delirium prior to the procedure
  • patients with severe central or peripheral nervous system disorders
  • patients with coagulation disorders or receiving anticoagulant therapy
  • pregnant or breastfeeding women
  • patients who received other medications or treatments prior to the procedure that might affect the study results
  • patients unable to cooperate with the study or intolerant to ultrasound-guided iliofascial block

研究组 & 干预措施

Group S1

Experimental

Before anesthesia induction, an iliac fascia block was administered using 0.375% ropivacaine (30 mL) under ultrasound guidance, followed by conventional anesthesia induction. During the anesthesia maintenance phase, dexmedetomidine was infused intravenously at a rate of 0.5 µg/kg/h.

干预措施: Dexmedetomidine Injection (Drug)

Group S2

Experimental

Before anesthesia induction, an iliac fascia block was administered using a mixture of 0.375% ropivacaine and 1ug/kg dexmedetomidine (30ml) under ultrasound guidance. During the anesthesia maintenance phase, an equivalent volume of 0.9% sodium chloride injection was infused intravenously.

干预措施: Ropivacaine and Dexmedetomidine (Drug)

Group C

Active Comparator

Before anesthesia induction, an iliac fascia block was performed using 0.375% ropivacaine (30 mL) under ultrasound guidance, followed by conventional anesthesia induction. During the anesthesia maintenance phase, an equivalent volume of 0.9% sodium chloride injection was infused intravenously.

干预措施: Sodium Chloride Injection (Drug)

结局指标

主要结局

Incidence of awakening agitation

时间窗: postoperative awakening period (1 min, 10 min, 20 min) and at the time of discharge from the PACU

Riker sedation-agitation scale (SAS) scores were recorded at various time points during the postoperative awakening period (1 min, 10 min, 20 min) and at the time of discharge from the PACU for each group. These scores were used to evaluate the sedation and agitation status of the patients.

次要结局

  • Analgesic effect(postoperative awakening period (1 min, 10 min, 20 min) and at the time of discharge from the PACU)
  • Ramesay score(postoperative awakening period (1 min, 10 min, 20 min) and at the time of discharge from the PACU)
  • Hemodynamic parameters(During operation)
  • Record of laryngeal mask removal time and adverse reactions(Within 24 hours after surgery)

研究者

发起方
Qianfoshan Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Pengcai Shi

Chief physician,Master Tutor

Qianfoshan Hospital

研究点 (1)

Loading locations...

相似试验